Herpes zoster of the trigeminal nerve third branch: a case report and review of the literature

Tidwell, E.; Hutson, B.; Burkhart, N.; Gutmann, James L.; Ellis, C.D.

doi:10.1046/j.1365-2591.1999.00187.x

Cited by 38 publications

(21 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Total duration of the disease is generally between 7 and 10 days; however, it may take several weeks for the hypopigmented skin to return to normal 5. Sometimes the vesicular rash does not appear (zoster sine herpete), which makes it difficult to diagnose 11. Surprisingly, pain is reported to subside when the rash is most active; however, it reverts back until the rash clears12 during the crusting and scale phase of the lesion.…”

Section: Discussionmentioning

confidence: 99%

Herpes zoster on the face in the elderly

et al. 2014

View full text Add to dashboard Cite

SUMMARYHerpes zoster is a localised disease caused by reactivation of the varicella zoster virus that enters the cutaneous nerve endings during an earlier episode of chicken pox, travels to the dorsal root ganglia, and remains in latent form. The condition is characterised by occurrence of multiple, painful, unilateral vesicles and ulceration, and shows a typical single dermatome innervated by single dorsal root or cranial sensory ganglion. Involvement of three or more dermatomes is known as disseminated zoster and seen in immunocompromised individuals. Complications of herpes zoster include ocular sequelae, bacterial superinfection of the lesions, meningoencephalitis and postherpetic neuralgia. The incidence of herpes zoster increases with age and immunosuppression, therefore prompt management is necessary to avoid morbidity and mortality in these individuals. We present two case reports of herpes zoster, one involving the maxillary and mandibular branches of the trigeminal nerve while the other involves all branches of the trigeminal nerve. BACKGROUND

show abstract

Section: Discussionmentioning

confidence: 99%

Herpes zoster on the face in the elderly

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Acyclovir has been the drug of choice for a number of years and other antiviral agents, such as famciclovir and valacyclovir, can also be used, (iv) the treatment of post-herpetic neuralgia includes the topical use of capsaicin cream, transcutaneous nerve stimulation, topical anesthetics, injected local anesthetics, and low dose amitriptyline 12) . Strommen et al 9) offered an in-depth review of the use of antidepressants and neurolyptics in the management …”

Section: ⅲ Discussionmentioning

confidence: 99%

Clinical diagnosis of herpes zoster presenting as odontogenic pain

Yang

Jung

Lee

et al. 2008

J Korean Acad Conserv Dent

View full text Add to dashboard Cite

Herpes zoster, an acute viral infection produced by the varicella zoster virus, may affect any of the trigeminal branches. This case report presents a patient with symptoms mimicking odontogenic pain. No obvious cause of the symptoms could be found based on clinical and radiographic examinations. After a dermatologist made a diagnosis of herpes zoster involving the third trigeminal branch, the patient was given antiviral therapy. Two months later, the facial lesions and pain had almost disappeared, and residual pigmented scars were present. During the diagnostic process, clinicians should keep in mind the possibility that orofacial pain might be related to herpes zoster. [J Kor Acad Cons Dent 33(5): [452][453][454][455][456] 2008]

show abstract

“…1,24 Carbamazepine is the drug of choice for the treatment of trigeminal neuralgia and is effective initially in 75% of cases. 2,25,26 Even though it has been reported that early administration of acyclovir will reduce the length of the cutaneous rash and the intensity of pain, 9,17,18,20,27,28 it has not been shown to result in a significant decrease in the incidence of post-herpetic neuralgia. 2 Six months after the onset of the HZ infection, our patient still had a 75% hearing loss.…”

Section: Discussionmentioning

confidence: 99%